Abano Healthcare Group Limited provided earnings guidance for the year ending May 31, 2015. For the period, the company expects gross revenues to be between NZD 299 million to NZD 303 million, revenues to be between NZD 221 million to NZD 225 million, EBITDA to be between NZD 29.1 million to NZD 30.1 million, net profit after tax (before impairment and loss on sale) to be between NZD 7.2 million to NZD 7.8 million, net loss after tax to be between NZD 1.3 million to NZD 1.9 million, underlying EBITDA to be between NZD 30.4 million to NZD 31.4 million and underlying NPAT to be between NZD 8.3 million to NZD 8.9 million.